Isolation of Apigenin from Sungkai ( Peronema canescens) Leaves and Its Immunomodulatory Effects: An In Vivo Study on Granzyme B, Interferon-γ, and Perforin Expression with Supporting In Silico Analysis.
{"title":"Isolation of Apigenin from Sungkai ( <i>Peronema canescens</i>) Leaves and Its Immunomodulatory Effects: An In Vivo Study on Granzyme B, Interferon-γ, and Perforin Expression with Supporting In Silico Analysis.","authors":"Dwisari Dillasamola, Yufri Aldi, Najmiatul Fitria, Biomechy Oktomalioputri, Uce Lestari, Risma Multia","doi":"10.12688/f1000research.167153.1","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong><i>Paronema canescens</i> Jack., commonly known as sungkai, is a medicinal plant native to Southeast Asia, particularly abundant in the forests of Sumatra and Borneo, Indonesia. Traditionally, sungkai has been used to treat various ailments, likely due to its rich content of bioactive secondary metabolites. This study aimed to isolate, characterize, and evaluate the immunostimulatory and anti-inflammatory potential of compounds from sungkai leaves based on in silico and in vivo analyses.</p><p><strong>Methods: </strong>Apigenin was isolated from <i>Paronema canescens</i> leaves via ethanol extraction, liquid-liquid partitioning, and chromatographic purification, then characterized by UV-Vis, FT-IR, and NMR spectroscopy. Molecular docking was conducted using MOE software to assess apigenin's binding to granzyme B, perforin, and IFN-γ, with levamisole as a reference. In vivo, 25 male mice were randomized into five groups and administered apigenin (1, 25, or 50 mg/kg BW) intramuscularly for seven days, alongside COVID-19 vaccination. Granzyme B and IFN-γ serum levels were quantified using ELISA. Statistical analysis employed one-way ANOVA with Duncan's test ( <i>p</i> < 0.05).</p><p><strong>Results: </strong>The <i>in silico</i> analysis demonstrated that apigenin exhibited favorable binding affinities and multiple stabilizing interactions with granzyme B, perforin, and interferon-γ, supporting its potential role in enhancing cellular immune responses through direct molecular modulation of key cytotoxic effector proteins. To assess its immunostimulatory activity in vivo, apigenin was orally administered to mice ( <i>Mus musculus</i>) at doses of 1, 25, and 50 mg/kg body weight. Mice were pre-induced with a COVID-19 vaccine to simulate immune system activation. Immunological responses were evaluated through the measurement of granzyme B, perforin, and interferon-γ expression levels. The results demonstrated that apigenin significantly increased the expression of all three markers in a dose-dependent manner.</p><p><strong>Conclusion: </strong>Collectively, the chemical, computational, and biological data confirm that apigenin from sungkai leaves holds strong immunostimulant and selective anti-inflammatory potential, supporting its development as a natural immune booster or vaccine adjuvant.</p>","PeriodicalId":12260,"journal":{"name":"F1000Research","volume":"14 ","pages":"774"},"PeriodicalIF":0.0000,"publicationDate":"2025-08-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC12481153/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"F1000Research","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.12688/f1000research.167153.1","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"2025/1/1 0:00:00","PubModel":"eCollection","JCR":"Q2","JCRName":"Pharmacology, Toxicology and Pharmaceutics","Score":null,"Total":0}
引用次数: 0
Abstract
Background: Paronema canescens Jack., commonly known as sungkai, is a medicinal plant native to Southeast Asia, particularly abundant in the forests of Sumatra and Borneo, Indonesia. Traditionally, sungkai has been used to treat various ailments, likely due to its rich content of bioactive secondary metabolites. This study aimed to isolate, characterize, and evaluate the immunostimulatory and anti-inflammatory potential of compounds from sungkai leaves based on in silico and in vivo analyses.
Methods: Apigenin was isolated from Paronema canescens leaves via ethanol extraction, liquid-liquid partitioning, and chromatographic purification, then characterized by UV-Vis, FT-IR, and NMR spectroscopy. Molecular docking was conducted using MOE software to assess apigenin's binding to granzyme B, perforin, and IFN-γ, with levamisole as a reference. In vivo, 25 male mice were randomized into five groups and administered apigenin (1, 25, or 50 mg/kg BW) intramuscularly for seven days, alongside COVID-19 vaccination. Granzyme B and IFN-γ serum levels were quantified using ELISA. Statistical analysis employed one-way ANOVA with Duncan's test ( p < 0.05).
Results: The in silico analysis demonstrated that apigenin exhibited favorable binding affinities and multiple stabilizing interactions with granzyme B, perforin, and interferon-γ, supporting its potential role in enhancing cellular immune responses through direct molecular modulation of key cytotoxic effector proteins. To assess its immunostimulatory activity in vivo, apigenin was orally administered to mice ( Mus musculus) at doses of 1, 25, and 50 mg/kg body weight. Mice were pre-induced with a COVID-19 vaccine to simulate immune system activation. Immunological responses were evaluated through the measurement of granzyme B, perforin, and interferon-γ expression levels. The results demonstrated that apigenin significantly increased the expression of all three markers in a dose-dependent manner.
Conclusion: Collectively, the chemical, computational, and biological data confirm that apigenin from sungkai leaves holds strong immunostimulant and selective anti-inflammatory potential, supporting its development as a natural immune booster or vaccine adjuvant.
F1000ResearchPharmacology, Toxicology and Pharmaceutics-Pharmacology, Toxicology and Pharmaceutics (all)
CiteScore
5.00
自引率
0.00%
发文量
1646
审稿时长
1 weeks
期刊介绍:
F1000Research publishes articles and other research outputs reporting basic scientific, scholarly, translational and clinical research across the physical and life sciences, engineering, medicine, social sciences and humanities. F1000Research is a scholarly publication platform set up for the scientific, scholarly and medical research community; each article has at least one author who is a qualified researcher, scholar or clinician actively working in their speciality and who has made a key contribution to the article. Articles must be original (not duplications). All research is suitable irrespective of the perceived level of interest or novelty; we welcome confirmatory and negative results, as well as null studies. F1000Research publishes different type of research, including clinical trials, systematic reviews, software tools, method articles, and many others. Reviews and Opinion articles providing a balanced and comprehensive overview of the latest discoveries in a particular field, or presenting a personal perspective on recent developments, are also welcome. See the full list of article types we accept for more information.